Abstract
Clinical and preclinical studies have shown that diabetic individuals present more depressive behaviors than non-diabetic individuals. Taurine, one of the most abundant free amino acids in the central nervous system, modulates a variety of biological functions and acts as an agonist at GABAA receptors. Our objective was to assess the antidepressant effect of taurine in diabetic rats. Additionally, we studied the effect of taurine on weight gain, water and food intake, and blood glucose levels in diabetic and non-diabetic rats. Male Wistar rats were divided into control (CTR) and streptozotocin-induced diabetic (STZ) groups and were administered daily 0, 25, 50 or 100 mg/kg of taurine (n = 10 per subgroup) intraperitoneally. After 28 days of treatment, the animals were exposed to the forced swimming test, and their behaviors were recorded. Weight gain, water and food intake, and blood glucose levels were measured weekly. Our results showed that STZ rats had a higher immobility duration than CTR rats, and taurine decreased this depressive-like behavior in STZ rats at doses of 25 and 100 mg/kg. Both of these doses of taurine also decreased water intake and improved weight gain in STZ rats. All doses of taurine decreased the water intake in CTR rats. Taurine, at a dose of 100 mg/kg, decreased food intake and blood glucose levels in STZ rats. Because taurine is a GABA agonist and both amino acids are lower in the plasma of diabetic and depressive individuals, we hypothesize that taurine may represent a new adjuvant drug for the treatment of depression in diabetic individuals.
Similar content being viewed by others
References
Albrecht J, Schousboe A (2005) Taurine interaction with neurotransmitter receptors in the CNS: an update. Neurochem Res 30:1615–1621
Anjaneyulu M, Chopra K, Kaur I (2003) Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice. J Med Food 6:391–395
Biessels GJ, van der Heide LP, Kamal A, Bleys RL, Gispen WH (2002) Aging and diabetes: implications for brain function. Eur J Pharmacol 441:1–14
Birdsall TC (1998) Therapeutic applications of taurine. Altern Med Rev 3:128–136
Bonner-Weir S (2000) Life and death of the pancreatic beta cells. Trends Endocrinol Metab 11:375–378
Brambilla P, Perez J, Barale F, Schettini G, Soares JC (2003) GABAergic dysfunction in mood disorders. Mol Psychiatry 8:721–737
Bustamante J, Lobo MV, Alonso FJ, Mukala NT, Gine E, Solis JM, Tamarit-Rodriguez J, Martin del Rio R (2001) An osmotic-sensitive taurine pool is localized in rat pancreatic islet cells containing glucagon and somatostatin. Am J Physiol Endocrinol Metab 281:E1275–E1285
Carneiro EM, Latorraca MQ, Araujo E, Beltrá M, Oliveras MJ, Navarro M, Berná G, Bedoya FJ, Velloso LA, Soria B, Martín F (2009) Taurine supplementation modulates glucose homeostasis and islet function. J Nutr Biochem 20:503–511
Champaneri S, Wand GS, Malhotra SS, Casagrande SS, Golden SH (2010) Biological basis of depression in adults with diabetes. Curr Diab Rep 10:396–405
Chen SW, Kong WX, Zhang YJ, Li YL, Mi XJ, Mu XS (2004) Possible anxiolytic effects of taurine in the mouse elevated plus-maze. Life Sci 75:1503–1511
Cherif H, Reusen B, Ahn MT, Hoet JJ, Remacle C (1998) Effects of taurine on the insulin secretion of rat fetal islets from dams fed a low protein diet. J Endocrinol 159:341–348
Daneman D (2006) Type 1 diabetes. Lancet 367:847–858
de Boer T, Bartels K, Metselaar HJ, Bruinvels J (1980) Di-n-propylacetate-induced abstinence behaviour as a possible correlate of increased GABA-ergic activity in the rat. Psychopharmacology 71:257–267
Del Prato S, Marchetti P (2004) Beta- and alpha-cell dysfunction in type 2 diabetes. Horm Metab Res 36:775–781
El Idrissi A, Trenkner E (2004) Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29:189–197
El Idrissi A, Messing J, Scalia J, Trenkner E (2003) Prevention of epileptic seizures by taurine. Adv Exp Med Biol 526:515–525
El Idrissi A, Boukarrou L, Heany W, Malliaros G, Sangdee C, Neuwirth L (2009) Effects of taurine on anxiety-like and locomotor behavior of mice. Adv Exp Med Biol 643:207–215
Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, Gironi A, Anichini R, Seghieri G (1995) Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 61:1115–1119
Franconi F, Miceli M, Fazzini A, Seghieri G, Caputo S, DiLeo MA, Lepore D, Ghirlanda G (1996) Taurine and diabetes. Humans and experimental models. Adv Exp Med Biol 403:579–582
Gavard JA, Lustman PJ, Clouse RE (1993) Prevalence of depression in adults with diabetes. Diabetes Care 16:1167–1178
Gavrovskaya LK, Ryzhova OV, Safonova AF, Matveev AK, Sapronov NS (2008) Protective effect of taurine on rats with experimental insulin-dependent diabetes mellitus. Bull Exp Biol Med 146:226–228
Gilon P, Bertrand G, Loubatieres-Mariani MM, Remacle C, Henquin JC (1991) The influence of gamma-aminobutyric acid on hormone release by the mouse and rat endocrine pancreas. Endocrinology 129:2521–2529
Gomez R, Barros HM (2000) Ethopharmacology of the antidepressant effect of clonazepam in diabetic rats. Pharmacol Biochem Behav 66:329–335
Gomez R, Vargas CR, Wajner M, Barros HM (2003) Lower in vivo brain extracellular GABA concentration in diabetic rats during forced swimming. Brain Res 968:281–284
Hansen SH (2001) The role of taurine in diabetes and the development of diabetes complications. Diabetes Metab Res Rev 17:330–346
Houston AJ, Wong JC, Ebenezer IS (2002) Effects of subcutaneous administration of the gamma-aminobutyric acid(A) receptor agonist muscimol on water intake in water-deprived rats. Physiol Behav 77:445–450
Hruska RE, Thut PD, Huxtable RJ, Bressler R (1975) Suppression of conditioned drinking by taurine and related compounds. Pharmacol Biochem Behav 3:593–599
Ichihara K, Nabeshima T, Kameyama T (1988) Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice. Pharmacol Biochem Behav 30:107–113
Jia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, Harrison NL (2008) Taurine is a potent activator of extrasynaptic Gaba A receptors in the thalamus. J Neurosci 28:106–115
Kulakowski EC, Maturo J (1984) Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 33:2835–2838
L’Amoreaux WJ, Cuttitta C, Santora A, Blaize JF, Tachjadi J, El Idrissi A (2010a) Taurine regulates insulin release from pancreatic beta cell lines. J Biomed Sci 17:S11
L’Amoreaux WJ, Marsillo A, El Idrissi A (2010b) Pharmacological characterization of GABAA receptors in taurine-fed mice. J Biomed Sci 17(S1):S14
Levinskaya N, Trenkner E, El Idrissi A (2006) Increased GAD-positive neurons in the cortex of taurine-fed mice. Adv Exp Med Biol 583:411–417
Luscher B, Shen Q, Sahir N (2011) The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16:383–406
Lustman PJ, Clouse RE (2005) Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat 19:113–122
Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23:934–942
Medina JH, DeRobertis E (1984) Taurine modulation of the benzodiazepine gamma–aminobutyric acid receptor complex in brain membranes. J Neurochem 42:1212–1217
Moriguchi S, Shioda N, Han F, Yeh JZ, Narahashi T, Fukunaga K (2009) Galantamine enhancement of long-term potentiation is mediated by calcium/calmodulin-dependent protein kinase II and protein kinase C activation. Hippocampus 19:844–854
Morishita S (2009) Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review. Hum Psychopharmacol 24:191–198
Murakami T, Furuse M (2010) The impact of taurine- and beta-alanine-supplemented diets on behavioral and neurochemical parameters in mice: antidepressant versus anxiolytic-like effects. Amino Acids 39:427–434
Nin MS, Salles FB, Azeredo LA, Frazon AP, Gomez R, Barros HM (2008) Antidepressant effect and changes of GABAA receptor gamma2 subunit mRNA after hippocampal administration of allopregnanolone in rats. J Psychopharmacol 22:477–485
Oja SS, Saransaari P (2007) Pharmacology of taurine. Proc West Pharmacol Soc 50:8–15
Perry TL, Bratty PJ, Hansen S, Kennedy J, Urquhart N, Dolman CL (1975) Hereditary mental depression and Parkinsonism with taurine deficiency. Arch Neurol 32:108–113
Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336
Ribeiro RA, Bonfleur ML, Amaral AG, Vanzela EC, Rocco SA, Boschero AC, Carneiro EM (2009) Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets. Diabetes Metab Res Rev 25:370–379
Sanacora G, Saricicek A (2007) GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets 6:127–140
Sanberg PR, Ossenkopp KP (1977) Dose–response effects of taurine on some open-field behaviors in the rat. Psychopharmacology (Berlin) 53(2):207–209
Schaffer SW, Azuma J, Mozaffari M (2009) Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 87:91–99
Sen S, Sanacora G (2008) Major depression: emerging therapeutics. Mt Sinai J Med 75:204–225
Singh-Franco D, Robles G, Gazze D (2007) Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus. Clin Ther 29:535–562
Smith WT, Londborg PD, Glaudin V, Painter JR (2002) Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression? J Affect Disord 70:251–259
Smith LA, Cornelius VR, Azorin JM, Perugi G, Vieta E, Young AH, Bowden CL (2010) Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. J Affect Disord 122:1–9
Sung MJ, Chang KJ (2009) Dietary taurine and nutrients intake and anthropometric and body composition data by abdominal obesity in Korean male college students. Adv Exp Med Biol 643:429–435
Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH et al (1995) Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am J Physiol 269:429–438
Tsuboyama-Kasaoka N, Shozawa C, Sano K, Kamei Y, Kasaoka S, Hosokawa Y, Ezaki O (2006) Taurine (2-aminoethanesulfonic acid) deficiency creates a vicious circle promoting obesity. Endocrinology 147:3276–3284
Vargas C, Tannhauser M, Tannhauser SL, Barros HM (1996) Lithium and valproate combined administration: acute behavioural effects and drug plasma levels. Pharmacol Toxicol 79:87–91
Walsh RN, Cummins RA (1976) The Open-Field Test: a critical review. Psychol Bull 83:482–504
Whirley BK, Einat H (2008) Taurine trials in animal models offer no support for anxiolytic, antidepressant or stimulant effects. Isr J Psychiatry Relat Sci 45:11–18
Wolffenbuttel BH, van Haeften TW (1995) Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM). Drugs 50:263–288
Wu JY, Prentice H (2010) Role of taurine in the central nervous system. J Biomed Sci 17:S1
Zhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S (2004) Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26:267–271
Acknowledgments
This work was supported by Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA) and Conselho Nacional de Desenvolvimento Científico e Tecnológico, CNPq. G.C. and H.B. receives a fellowship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, CAPES, and H.B. received a CNPq 1C Researcher Productivity Grant.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caletti, G., Olguins, D.B., Pedrollo, E.F. et al. Antidepressant effect of taurine in diabetic rats. Amino Acids 43, 1525–1533 (2012). https://doi.org/10.1007/s00726-012-1226-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-012-1226-x